glucuronic acid has been researched along with Tuberculosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garg, T; Goyal, AK; Murthy, RS; Rath, G | 1 |
| Ajdary, S; Bayati, K; Dobakhti, F; Naghibi, T; Rafiee-Tehrani, M; Rafiei, S; Rafinejad, A; Taghikhani, M | 1 |
| Ali, A; Aqil, M; Chuttani, K; Kumar, D; Maurya, DP; Mishra, AK; Sultana, Y | 1 |
| Choonara, YE; du Toit, LC; Jarvis, DL; Khan, RA; Kumar, P; Murphy, CS; Ndesendo, VM; Pillay, V | 1 |
| ROSS, JD; SCHILLER, E; WALLACE, AT | 1 |
| HATORI, H | 1 |
| TAKAHASHI, H | 1 |
| KAKU, T | 1 |
| Khuller, GK; Pandey, R | 1 |
| Ahmad, Z; Khuller, GK; Sharma, S; Zahoor, A | 1 |
| Ahmad, Z; Khuller, GK; Sharma, S | 1 |
11 other study(ies) available for glucuronic acid and Tuberculosis
| Article | Year |
|---|---|
Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.
Topics: Administration, Inhalation; Alginates; Animals; Antitubercular Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Female; Glucuronic Acid; Hexuronic Acids; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Particle Size; Rifampin; Tuberculosis | 2016 |
Adjuvanticity effect of sodium alginate on subcutaneously injected BCG in BALB/c mice.
Topics: Adjuvants, Immunologic; Alginates; Animals; Antibodies, Bacterial; BCG Vaccine; Colony Count, Microbial; Female; Glucuronic Acid; Hexuronic Acids; Hypersensitivity, Delayed; Immunoglobulin G; Injections, Subcutaneous; Interferon-gamma; Lung; Mice; Mice, Inbred BALB C; Tuberculosis | 2009 |
Formulation and optimization of alkaline extracted ispaghula husk microparticles of isoniazid - in vitro and in vivo assessment.
Topics: Adhesiveness; Alginates; Animals; Antitubercular Agents; Calorimetry, Differential Scanning; Cross-Linking Reagents; Drug Carriers; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Isoniazid; Particle Size; Plantago; Psyllium; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Tuberculosis; X-Ray Diffraction | 2011 |
Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers.
Topics: Alginates; Calcium Chloride; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Emulsions; Glucuronic Acid; Hexoses; Hexuronic Acids; Humans; Hydrogels; Isoniazid; Lactic Acid; Microscopy, Electron, Scanning; Models, Molecular; Nanoparticles; Organic Chemistry Phenomena; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Spectrum Analysis; Thermodynamics; Tuberculosis | 2011 |
Laryngeal swabs for isolation of tubercle bacilli; including a trial of calcium alginate wool as swab material.
Topics: Alginates; Animals; Bacillus; Bacteriology; Glucuronic Acid; Hexuronic Acids; Humans; Larynx; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Pulmonary; Wool | 1955 |
[Effect of old tuberculin combined with a glucuronic acid (GLT) phenylhydrazine fraction on experimental tuberculosis].
Topics: Glucuronates; Glucuronic Acid; Phenylhydrazines; Tuberculin; Tuberculosis | 1960 |
[On the metabolism of PAS. IV. With special reference to the different forms of glucuronic acid in PAS-glycosuria].
Topics: Aminosalicylic Acid; Body Fluids; Glucuronates; Glucuronic Acid; Glycosuria; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[EFFECTIVENESS OF IRON GLUCURONATE ON ANEMIA IN TUBERCULOSIS].
Topics: Anemia; Glucuronates; Glucuronic Acid; Humans; Iron; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers.
Topics: Alginates; Animals; Antitubercular Agents; Chitin; Chitosan; Drug Carriers; Female; Glucuronic Acid; Guinea Pigs; Hexuronic Acids; Male; Microspheres; Tissue Distribution; Tuberculosis | 2004 |
Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.
Topics: Aerosols; Alginates; Animals; Antitubercular Agents; Drug Carriers; Drug Evaluation, Preclinical; Female; Glucuronic Acid; Guinea Pigs; Hexuronic Acids; Inhalation; Isoniazid; Liver; Lung; Male; Mycobacterium tuberculosis; Nanostructures; Pyrazinamide; Rifampin; Spleen; Time Factors; Tuberculosis | 2005 |
Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis.
Topics: Alginates; Animals; Antibiotics, Antitubercular; Antifungal Agents; Azoles; Capsules; Diffusion; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Female; Glucuronic Acid; Hexuronic Acids; Male; Mice; Nanoparticles; Particle Size; Treatment Outcome; Tuberculosis | 2007 |